Fred Hutch grew from a regional cancer center into a world-class biomedical research and clinical care institution known for ...

In a personal essay for PEOPLE, TikTok star Eldiara Doucette opens up about her recurring soft tissue cancer, losing her ...

The FDA has granted BTD to GSK’22, a B7-H3-targeted antibody-drug conjugate, for the treatment of adult patients with ...

The newly approved methastatic Renal Cell Cancer (mRCC) Phase 1/2a trial began in Q4 2024, and Genenta expects to treat six patients by the end of the first half of 2025, while continuing progress ...

Researchers developed and validated a nomogram to predict 1-, 2-, and 3-year overall survival (OS) in patients with ovarian ...

Machine learning doesn’t replace humans. But AI does assist them in doing their job better by helping predict the success – ...

A young father - and die-hard Buffalo Bills fan - is facing the fight of his life after being diagnosed with a rare cancer.

Endocrinology specialist Dr Preethi Dissanayake discusses this uncommon presentation, in the latest in our series on ...

Onkos Surgical, a leading provider of innovative solutions for complex orthopaedic procedures, today announced that its ...

In fact, from Merck's $1.3 billion deal to GSK's $850 million investment, the "gold content" of Chinese companies' self-developed TCE bispecific antibodies has already been well proven. The new moves ...

Genenta Science (NASDAQ: GNTA), a pioneer in immuno-oncology and a leader in cell-based therapeutics, is pleased to announce that it has strengthened ...